Evaluation of Emdogain® antimicrobial effectiveness against biofilms containing the keystone pathogen Porphyromonas gingivalis

New Microbiol. 2018 Jan;41(1):73-76. Epub 2018 Jan 9.

Abstract

This study aimed to evaluate the antimicrobial activity of Emdogain® (EMD) against biofilms containing the periopathogen Porphyromonas gingivalis. A brain-Heart infusion broth inoculated with S. gordonii and P. gingivalis was perfused (7-d, anaerobiosis) through a closed circuit containing two Robbins devices as to form biofilms. The latter were then treated for 2 min with various antimicrobials (Chlorhexidine (CHX) 0.2%, Povidone iodine (PVI) 5%, PVI 10%, essential oils (EO), EO ZeroTM or EMD) (n=8) and cell densities were calculated and compared. In the present in vitro model, Emdogain® was not statistically effective (p>0.05) in killing biofilm bacteria unlike the other tested molecules.

Keywords: Biofilm; antimicrobial; enamel matrix derivative; periimplantitis; periodontitis.

MeSH terms

  • Biofilms / drug effects*
  • Biofilms / growth & development
  • Culture Media
  • Dental Enamel Proteins / pharmacology*
  • Porphyromonas gingivalis / drug effects*
  • Porphyromonas gingivalis / physiology

Substances

  • Culture Media
  • Dental Enamel Proteins
  • enamel matrix proteins